Navigation Links
Schering-Plough Schedules Conference Call Webcast for 2009 Second Quarter Earnings
Date:6/29/2009

KENILWORTH, N.J., June 29 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) is scheduled to announce its sales and earnings results for the 2009 second quarter on Tuesday, July 21, 2009.

At approximately 7:45 a.m. (EDT) on that day, Schering-Plough will conduct a conference call to review results for the 2009 second quarter. Fred Hassan, Schering-Plough's chairman and CEO, and other members of management will host the conference call.

To listen live to the call, dial 1-866-871-2144 or 1-706-634-5003 and enter conference ID # 13268740. A replay of the call will be available beginning later on July 21 through 5 p.m. on Tuesday, July 28. To listen to the replay, dial 1-800-642-1687 or 1-706-645-9291 and enter the conference ID # 13268740. A live audio webcast of the conference call also will be available by going to the Investor Relations section of the Schering-Plough corporate Web site, www.schering-plough.com, and clicking on the "Presentations/Webcasts" link. A replay of the webcast will be available starting on July 21 through 5 p.m. on August 21.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
2. Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD
3. Schering-Plough Schedules Webcast For Annual Meeting of Shareholders
4. Schering-Plough Schedules Conference Call Webcast for 2009 First Quarter Earnings
5. Schering-Plough to Webcast Presentation at Barclays Capital Global Healthcare Conference
6. Video: Schering-Plough Introduces AFRIN(R) PureSea(TM): A Natural, Gentle Nasal Rinse From the Seas of Northern France
7. Novartis/Schering-Ploughs Drug Will Replace AstraZenecas Symbicort as Decision Resources Clinical Gold Standard by 2012 for the Treatment of Asthma
8. Schering-Plough Announces Collaboration With World Health Organization to Provide Access to Pandemic Influenza Vaccine Technology to Developing Countries
9. Schering-Plough Submits Response to FDA for SAPHRIS(TM) (asenapine) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
10. Schering-Plough to Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
11. HUYA Bioscience Announces Agreement to Provide Schering-Plough With Drug Development Candidates From China

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., TORONTO, Nov. 6 /PRNewswire-FirstCall/ - Microb... that it has re-filed the Form 52-109F1 Certificat... Executive Officer and James Long, the Chief Finan...January 12, 2009 in connection with the annual aud...mber 30, 2008. ,, The Company initially filed t...
(Date:11/6/2009)..., VIENNA, Austria, November 6 ...zing, manufacturing, and marketing enzymes for the...ered into a research,agreement with Bio Sidus, the...a. , The agreement gives EUCODIS Bioscien... interest - to Bio Sidus, proprietary collection o...
(Date:11/6/2009)..., HAYWARD, Calif., Nov. 6 Intarci...oday on its ITCA 650 (DUROS® continuous deliv...e 2 diabetes at the Ninth Annual Diabetes Technolo...p://www.newscom.com/cgi-bin/prnh/20050301/SFTU126L...Exenatide Via ITCA 650 Lowers Plasma Glucose, HbA1...
(Date:11/5/2009)..., WELLINGTON, Colo., Nov. 5 The e... towns in the western U.S. This rare carnivore fe...usceptible to plague and often entire population d...ife Service (FWS) has implemented a ferret breedin...ferrets into their formerly native habitat. Unfor...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2
.... 28 XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB ...009 it received a Staff Determination Letter (the ...notifying the Company that the staff of Nasdaq,s L... its discretionary authority under Nasdaq Marketpl...ory Shares ("ADRs") would be delisted from Nasdaq....
...Clinical Force, a web based CTMS (Clinical Trial M...lected its solution. "We have deployed visit ...line client currently. Future phases of our projec...capture and possibly our financial system, as well...tem that will give us clear advantages in the serv...
...With the pre-registration period for the European ...ization and restriction of Chemicals) having ended...business segment of SAFC(R), a member of the Sigma...ive research into which products would be required...ed its capacity to supply the products deemed crit...
Other Biology Technology:AAIPharma Deploys Clinical Force CTMS (Clinical Trials Management System) 2AAIPharma Deploys Clinical Force CTMS (Clinical Trials Management System) 3SAFC Adopts Targeted Approach to Reach Pre-Registration 2SAFC Adopts Targeted Approach to Reach Pre-Registration 3SAFC Adopts Targeted Approach to Reach Pre-Registration 4
(Date:11/5/2009)...e University have developed synthetic molecules ca...IV and HIV-infected cells, as well as to prostate ...the Journal of the American Chemical Society , co... diseases. , The molecules called "antibody-re...body-recruiting molecule targeting prostate cancer...
(Date:11/4/2009)...ence) , United States Using Less Water Today ...t did 35 years ago, despite a 30 percent populatio...butable to alternative cooling methods at power pl...ing to the latest USGS water use report, nearly ha...cooling thermoelectric power plants. Irrigation ac...
(Date:11/4/2009)... turns out, hold the power to help militaries and ...ean up toxic waste on test sites. , Compounds kn... back in World War II and have been used in milita...unds are often used to propel tank shells and act ...h increased knowledge of their environmentally har...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Genomic research will enable greener cleanup of military explosive test sites 2ProFibrix Initiates Phase II Clinical Trial of its Lead Topical Hemostat Product Fibrocaps 28TM 29 4611 1Congress Appeals to Obama Administration Thailand 3A Stop Hmong Returns to Laos 49312 1Congress Appeals to Obama Administration Thailand 3A Stop Hmong Returns to Laos 49312 2Common fish species has human ability to learn 8889 1Common fish species has human ability to learn 8889 2Common fish species has human ability to learn 8889 3
...rug Discovery (LSCDD), Singapore,s National Neuros...e for Clinical Sciences (SICS), have teamed up to ...em cells. , NNI is one of the institutions of Si...ingapore. LSCDD, a wholly owned subsidiary of the ...Company has recently expanded its facility at the ...
..., methyl bromide (MB) has been the foundation for ...trawberries. MB, classified as a Class I stratosph... since 2005, but is still being used in strawberry...wberry production is important to California,s eco...ction. In 2006, the fruit harvest yielded a value ...
... Mycotoxin Research have signed an agreement to pu...h , the official journal of the Society. Aimed at...roducing industry, the journal deals with all topi...oduced by molds. The first issue will appear in M...s and review articles in Mycotoxin Research addr...
Other Biology News:Singapore research organisations team up to advance drug discovery using brain tumor stem cells 2Methyl bromide alternatives for California strawberry nurseries 2Mycotoxin Research joins Springer's life sciences journals program 2
Chicken Anti-Human QPRT Polyclonal Antibody, Unconjugated from ProSci, Inc
HRP Protein Marker Detection Pack from New England Biolabs
Mouse Anti-Y14 Monoclonal Antibody, Unconjugated, Clone 4C4 from Abcam
Rabbit Anti-Human JMJD2B Polyclonal Antibody, Unconjugated from ProSci, Inc
Biology Products: